Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Hematology & Oncology
Published in: Journal of Hematology & Oncology 1/2010

Open Access 01-12-2010 | Letter to the Editor

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma

Authors: Jean-Christophe Ianotto, Adrian Tempescul, Jean-Richard Eveillard, Norbert André, Frederic Morel, Isabelle Quintin-Roué, Christian Berthou

Published in: Journal of Hematology & Oncology | Issue 1/2010

Login to get access

Abstract

Background

Mantle cell lymphoma is a lymphoid entity characterized by adenopathy, blood and bone marrow involment which only recurrent mucosal localisation is the lymphomatoid polyposis. Few other mucosal infiltrations have been already reported.

Results

We report here the first case of a unique tracheal localisation of mantle cell lymphoma at presentation of the disease. The presence of classical t(11;14)(q13;q32) confirmed the diagnosis of mantle cell lymphoma by eliminating MALT or cancer localisation.

Conclusion

This case illustrates the necessity to ensure the diagnosis of mucosal lymphoma versus MCL since these diseases need different treatment regimens and prognoses.
Appendix
Available only for authorised users
Literature
1.
Campo E, Raffeld M, Jaffe ES: Mantle-cell lymphoma. Seminars in Hematology. 1999, 36: 115-127.PubMed
2.
Rao DS, Said JW: Small lymphoid proliferations in extranodal locations. Archives of Pathology and Laboratory Medicine. 2007, 131: 383-396.PubMed
3.
Okubo K, Miyamoto N, Komaki C: Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the trachea: a case of surgical resection and long term survival. Thorax. 2005, 60: 82-83. 10.1136/thx.2003.018721.PubMedCentralCrossRefPubMed
4.
Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, Molica S, Zaccaria A, Cantonetti AM, Gentilini P, Guardigni L, Gherlinzoni F, Ribersani M, Bendandi M, Albertini P, Tura S: Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. Journal of Clinical Oncology. 1999, 17: 1254-PubMed
5.
Jaffe ES: Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis. Modern Pathology. 2002, 15: 255-263. 10.1038/modpathol.3880521.CrossRefPubMed
6.
Amemiya M, Takise A, Kaira K, Endou K, Horie T, Inazawa M: Obstructive sleep apnea syndrome in a patient with superior vena cava syndrome caused by malignant lymphoma. Nihon Kokyuki Gakkai Zasshi. 2006, 44: 197-201.PubMed
7.
Kuppusamy Gounder S, Sikder M, Srinivas S, Chang VT, Kasimis B: Asymptomatic mantle cell lymphoma in the trachea. Leukemia Lymphoma. 2009, 50: 651-652. 10.1080/10428190902718818.CrossRefPubMed
8.
Verde F, McGeehan A: Endotracheal involvement as an unusual extranodal site of recurrence from mantle cell lymphoma. Radiolology Case Report. 2008, 3: 194-Online
Metadata
Title
Acute dyspnoea and single tracheal localisation of mantle cell lymphoma
Authors
Jean-Christophe Ianotto
Adrian Tempescul
Jean-Richard Eveillard
Norbert André
Frederic Morel
Isabelle Quintin-Roué
Christian Berthou
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2010
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-3-34

Other articles of this Issue 1/2010

Journal of Hematology & Oncology 1/2010 Go to the issue

Research

CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation

Short report

Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy?

Research

The frequency of NPM1 mutations in childhood acute myeloid leukemia

Review

Angiogenesis inhibitors in the treatment of prostate cancer

Short report

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Case report

Prozone effect of serum IgE levels in a case of plasma cell leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits